SITEC pharmabio

SITEC pharmabio is rated 3 out of 5 in the category pharmaceuticals. Read and write reviews about SITEC pharmabio. SiTec PharmaBio focuses on the evaluation and development of innovative technologies for drug formulation and drug delivery. SiTec has a collaboration agreement and an exclusive licence with Messer Group, for the development and application of a novel, proprietary, CO2 dense gas technology (Variosol®), in life-sciences sectors. When expanding from near-critical conditions, CO2 has favorable physical properties as a spraying agent and refrigerant, and it can be used as an atomizing and crystallizing medium, generating microparticles with narrow size distribution and improved biopharmaceutical properties. Variosol® can address many technical and economical challenges faced today by pharmaceutical industry. It offers significant advantages over existing micronization methods and over supecritical fluid based processes. Also, SiTec offers consulting services and training to pharma and biotech companies in the areas of early stage product development and drug delivery.